• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个实用的在线工具,用于估算艾滋病毒感染者和易感人群的抗逆转录病毒覆盖率,以减少当地的艾滋病毒流行。

A practical online tool to estimate antiretroviral coverage for HIV infected and susceptible populations needed to reduce local HIV epidemics.

机构信息

Division of Infectious Diseases, University of California, San Diego, La Jolla, California, United States of America.

Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

出版信息

Sci Rep. 2016 Jun 24;6:28707. doi: 10.1038/srep28707.

DOI:10.1038/srep28707
PMID:27337983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4919622/
Abstract

It remains unclear what proportions of HIV-infected and uninfected people should receive effective antiretroviral therapy (ART) to control local HIV epidemics. We developed a flexible model to evaluate the impact of treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP) on HIV incidence in local communities. We evaluated this tool for determining what TasP and PrEP targets are needed to substantially reduce the HIV epidemic in San Diego, which is predominately comprised of men who have sex with men. By increasing the proportion of HIV-infected individuals on ART from 30% to 50%, 686 new infections would be prevented over five years in San Diego. By providing PrEP to 30% of MSM to the age group that account for 90% of local HIV incident cases (21-52 years), we could prevent 433 infections over five years. When combining these initiatives, a PrEP coverage rate of 40% and TasP coverage rate of 34% would be expected to decrease the number of new infections by over half in one year. This online tool is designed to help local public health planners and policy makers to estimate program outcomes and costs that may lead to better control of their local HIV epidemics.

摘要

目前尚不清楚应该让多大比例的 HIV 感染者和未感染者接受有效的抗逆转录病毒治疗(ART)以控制当地的 HIV 流行。我们开发了一个灵活的模型来评估治疗即预防(TasP)和暴露前预防(PrEP)对当地社区 HIV 发病率的影响。我们评估了这一工具,以确定在以男男性行为者为主的圣地亚哥,需要达到什么样的 TasP 和 PrEP 目标才能大幅减少 HIV 流行。将接受抗逆转录病毒治疗的 HIV 感染者比例从 30%提高到 50%,圣地亚哥将在五年内预防 686 例新感染。通过向占当地 HIV 发病病例 90%的年龄组(21-52 岁)的 30%的男男性行为者提供 PrEP,我们可以在五年内预防 433 例感染。如果将这些措施结合起来,预计 PrEP 覆盖率达到 40%,TasP 覆盖率达到 34%,将使一年的新感染人数减少一半以上。这个在线工具旨在帮助当地公共卫生规划者和决策者估计可能导致更好地控制当地 HIV 流行的项目结果和成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ce/4919622/bd5dbc62019d/srep28707-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ce/4919622/eb58d0615fa1/srep28707-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ce/4919622/10ebb486f480/srep28707-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ce/4919622/8c3a0a078d68/srep28707-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ce/4919622/bd5dbc62019d/srep28707-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ce/4919622/eb58d0615fa1/srep28707-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ce/4919622/10ebb486f480/srep28707-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ce/4919622/8c3a0a078d68/srep28707-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ce/4919622/bd5dbc62019d/srep28707-f4.jpg

相似文献

1
A practical online tool to estimate antiretroviral coverage for HIV infected and susceptible populations needed to reduce local HIV epidemics.一个实用的在线工具,用于估算艾滋病毒感染者和易感人群的抗逆转录病毒覆盖率,以减少当地的艾滋病毒流行。
Sci Rep. 2016 Jun 24;6:28707. doi: 10.1038/srep28707.
2
Elimination prospects of the Dutch HIV epidemic among men who have sex with men in the era of preexposure prophylaxis.暴露前预防时代男男性行为人群中荷兰 HIV 流行消除的前景。
AIDS. 2018 Nov 13;32(17):2615-2623. doi: 10.1097/QAD.0000000000002050.
3
The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.在尼日利亚,使用抗逆转录病毒疗法预防处于HIV血清转化高风险人群中的新发HIV感染。
Afr J Reprod Health. 2014 Sep;18(3 Spec No):127-34.
4
PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study.内罗毕关键人群联合 HIV 预防中的 PrEP:一项数学建模研究。
Lancet HIV. 2017 May;4(5):e214-e222. doi: 10.1016/S2352-3018(17)30021-8. Epub 2017 Feb 21.
5
Prevalence and characteristics of users of pre-exposure prophylaxis (PrEP) among men who have sex with men, San Francisco, 2014 in a cross-sectional survey: implications for disparities.2014年旧金山一项横断面调查中男男性行为者中暴露前预防(PrEP)使用者的患病率及特征:对差异的影响
Sex Transm Infect. 2017 Feb;93(1):52-55. doi: 10.1136/sextrans-2015-052382. Epub 2016 Jun 28.
6
Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool.欧洲男男性行为者的暴露前预防(PrEP):对一种急需的预防工具的证据综述
Sex Transm Infect. 2017 Aug;93(5):363-367. doi: 10.1136/sextrans-2016-052699. Epub 2016 Nov 21.
7
The global response to HIV in men who have sex with men.全球应对男男性行为人群中的艾滋病毒问题。
Lancet. 2016 Jul 9;388(10040):198-206. doi: 10.1016/S0140-6736(16)30781-4.
8
Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men.验证治疗能否消除艾滋病毒的假设:一项基于丹麦男男性行为者艾滋病毒流行情况的全国性人群研究。
Lancet Infect Dis. 2016 Jul;16(7):789-796. doi: 10.1016/S1473-3099(16)30022-6. Epub 2016 May 9.
9
[Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?].[基于抗逆转录病毒药物的艾滋病预防方法:对艾滋病流行有何影响?]
Med Sci (Paris). 2013 Apr;29(4):373-82. doi: 10.1051/medsci/2013294010. Epub 2013 Apr 26.
10
Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.在法国国家艾滋病研究机构(ANRS)的IPERGAY试验中,男男性行为者(MSM)对暴露前预防(PrEP)的接受情况、避孕套使用情况及性风险行为
AIDS Care. 2016;28 Suppl 1(sup1):48-55. doi: 10.1080/09540121.2016.1146653. Epub 2016 Feb 17.

引用本文的文献

1
Web-based models to inform health policy: A scoping review.用于为卫生政策提供信息的基于网络的模型:一项范围综述。
Health Res Policy Syst. 2025 Aug 4;23(1):99. doi: 10.1186/s12961-025-01367-z.
2
Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted?男男性行为者中低艾滋病毒感染率地区的暴露前预防(PrEP):是否应针对高危人群?
Sci Rep. 2018 Aug 3;8(1):11641. doi: 10.1038/s41598-018-30101-9.
3
Elevated HIV Prevalence and Correlates of PrEP Use Among a Community Sample of Black Men Who Have Sex With Men.

本文引用的文献

1
How to beat HIV.如何战胜艾滋病病毒。
Nature. 2015 Jul 9;523(7559):146-8. doi: 10.1038/523146a.
2
Targeting HIV Prevention Based on Molecular Epidemiology Among Deeply Sampled Subnetworks of Men Who Have Sex With Men.基于男男性行为者深度抽样子网分子流行病学的艾滋病预防靶向研究
Clin Infect Dis. 2015 Nov 1;61(9):1462-8. doi: 10.1093/cid/civ526. Epub 2015 Jun 30.
3
"Any Condomless Anal Intercourse" is No Longer an Accurate Measure of HIV Sexual risk Behavior in Gay and Other Men Who have Sex with Men.“无保护肛交”不再是男同性恋者和其他男男性行为者中 HIV 性风险行为的准确衡量标准。
黑人男男性行为者社区样本中 HIV 流行率升高和 PrEP 使用的相关性。
J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):339-346. doi: 10.1097/QAI.0000000000001822.
4
What Can We Do or Change to Encourage People to Seek Out Preexposure Prophylaxis?我们可以做些什么或做出哪些改变来鼓励人们寻求暴露前预防?
Am J Public Health. 2017 Dec;107(12):1862-1864. doi: 10.2105/AJPH.2017.304149.
Front Immunol. 2015 Feb 27;6:86. doi: 10.3389/fimmu.2015.00086. eCollection 2015.
4
The lifetime medical cost savings from preventing HIV in the United States.在美国,预防艾滋病病毒所节省的终身医疗费用。
Med Care. 2015 Apr;53(4):293-301. doi: 10.1097/MLR.0000000000000308.
5
Human immunodeficiency virus transmission at each step of the care continuum in the United States.美国关爱连续体各环节中的人类免疫缺陷病毒传播。
JAMA Intern Med. 2015 Apr;175(4):588-96. doi: 10.1001/jamainternmed.2014.8180.
6
Understanding the HIV disparities between black and white men who have sex with men in the USA using the HIV care continuum: a modeling study.利用艾滋病病毒护理连续体了解美国男男性行为者中黑人和白人之间的艾滋病病毒差异:一项建模研究。
Lancet HIV. 2014 Dec;1(3):e112-e118. doi: 10.1016/S2352-3018(14)00011-3.
7
Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011.生命体征:美国2011年艾滋病毒感染者中的艾滋病毒诊断、护理及治疗情况
MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1113-7.
8
Will risk compensation accompany pre-exposure prophylaxis for HIV?暴露前预防艾滋病病毒会伴随风险补偿吗?
Virtual Mentor. 2014 Nov 1;16(11):909-15. doi: 10.1001/virtualmentor.2014.16.11.stas1-1411.
9
Two years of Truvada for pre-exposure prophylaxis utilization in the US.在美国,两年使用特鲁瓦达进行暴露前预防。
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19730. doi: 10.7448/IAS.17.4.19730. eCollection 2014.
10
HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.临床护理环境中的HIV预防:美国国际抗病毒学会专家组2014年建议
JAMA. 2014;312(4):390-409. doi: 10.1001/jama.2014.7999.